BMP-2 Amplifier Composition for Controlled Osteoconductive Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing bone graft materials are only osteoconductive and lack efficient delivery systems for synthetic growth factors like BMP-2 amplifiers/co-activators, leading to suboptimal bone healing and potential exuberant bone production.
Innovation Solution
A composition comprising a synthetic growth factor analogue, such as B2A2-K-NS, is attached to and released from an osteoconductive material, acting as an amplifier/co-activator of osteoinduction, with tailored release kinetics to enhance bone repair processes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If synthetic growth factors are added to bone graft materials, then osteoinduction is enhanced, but uncontrolled release leads to exuberant bone production and suboptimal healing
Solution Approach 1:
The patent applies dynamics by creating a delivery system where the release of synthetic growth factors is not static but dynamically controlled over time. The bone graft material is designed to release BMP-2 amplifiers/co-activators in a temporally controlled manner, matching the natural bone healing process stages, thereby preventing both insufficient and excessive bone production.
Solution Approach 2:
The patent utilizes parameter changes by modifying the physical and chemical properties of the bone graft material to control release kinetics. By adjusting parameters such as material composition, porosity, and surface characteristics, the system achieves controlled differential release of growth factors, optimizing bone healing while preventing exuberant bone production.
2Reliability
If osteoconductive materials are used as scaffolds, then bone growth is supported, but they lack the ability to deliver growth factors efficiently
Solution Approach 1:
The patent merges two previously separate functions into a single integrated system: the osteoconductive scaffold and the growth factor delivery system. By combining these functions, the bone graft material simultaneously provides structural support for bone growth and efficiently delivers synthetic growth factors, resolving the limitation of osteoconductive materials lacking delivery capability.
Solution Approach 2:
The patent applies universality by designing a bone graft material that performs multiple functions: osteoconduction (providing scaffold), osteoinduction (delivering growth factors), and controlled release (temporal regulation). This multi-functional system eliminates the need for separate delivery mechanisms and optimizes overall bone healing efficacy.
3Duration of action of stationary object
If growth factors are released continuously, then osteoinduction is maintained, but bone healing becomes uncontrolled and inefficient
Solution Approach 1:
The patent applies periodic action by designing the bone graft material to release growth factors in distinct phases or periods that correspond to different stages of bone healing. Instead of continuous release, the system provides pulsed or staged delivery, maintaining osteoinduction duration while improving bone healing efficiency through temporally appropriate growth factor availability.
Data Source
AI summary
A composition comprising a synthetic growth factor analogue comprising a non-growth factor heparin binding region, a linker and a sequence that binds specifically to a cell surface receptor and an osteoconductive material where the synthetic growth factor analogue is attached to and can be released from the osteoconductive material and is an amplifier/co-activator of osteoinduction.